Rocket


News + Filings
Transactions





LaBrosse Nicole

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
02/16/2023HALOZYME THERAPEUTICS, INC.HALOSaleCommon Stock2.5k$49.26$124.4k 02/16/2023
02/16/2023HALOZYME THERAPEUTICS, INC.HALOExerciseRestricted Stock Units5.1k$0.00$0 02/16/2023
02/16/2023HALOZYME THERAPEUTICS, INC.HALOGrantOption to Purchase Common Stock61.1k$49.26$3M 02/16/2023
02/16/2023HALOZYME THERAPEUTICS, INC.HALOGrantRestricted Stock Units21.3k$0.00$0 02/16/2023
02/12/2023HALOZYME THERAPEUTICS, INC.HALOPayment of ExerciseCommon Stock681$48.92$33.3k 02/10/2023
02/12/2023HALOZYME THERAPEUTICS, INC.HALOExerciseRestricted Stock Units1.4k$0.00$0 02/10/2023
02/10/2023HALOZYME THERAPEUTICS, INC.HALOExerciseRestricted Stock Units2.5k$0.00$0 02/10/2023
02/10/2023HALOZYME THERAPEUTICS, INC.HALOPayment of ExerciseCommon Stock1.4k$48.92$68.1k 02/10/2023
11/15/2022HALOZYME THERAPEUTICS, INC.HALOSaleCommon Stock4.6k$53.82$249.5k 11/15/2022
11/15/2022HALOZYME THERAPEUTICS, INC.HALOSaleCommon Stock365$53.69$19.6k 11/15/2022
02/16/2022HALOZYME THERAPEUTICS, INC.HALOGrantOption to Purchase Common Stock62.3k$34.36$2.1M 02/15/2022
02/16/2022HALOZYME THERAPEUTICS, INC.HALOGrantRestricted Stock Units20.4k$0.00$0 02/15/2022
02/15/2022HALOZYME THERAPEUTICS, INC.HALOPayment of ExerciseCommon Stock433$34.43$14.9k 02/15/2022
02/15/2022HALOZYME THERAPEUTICS, INC.HALOExerciseRestricted Stock Units1.3k$0.00$0 02/15/2022
02/14/2022HALOZYME THERAPEUTICS, INC.HALOPayment of ExerciseCommon Stock427$33.64$14.4k 02/10/2022
02/14/2022HALOZYME THERAPEUTICS, INC.HALOExerciseRestricted Stock Unit1.3k$0.00$0 02/10/2022
02/12/2022HALOZYME THERAPEUTICS, INC.HALOExerciseRestricted Stock Units1.4k$0.00$0 02/10/2022
02/12/2022HALOZYME THERAPEUTICS, INC.HALOPayment of ExerciseCommon Stock506$34.20$17.3k 02/10/2022
02/10/2022HALOZYME THERAPEUTICS, INC.HALOPayment of ExerciseCommon Stock1k$34.94$35.8k 02/10/2022
02/10/2022HALOZYME THERAPEUTICS, INC.HALOExerciseRestricted Stock Units2.5k$0.00$0 02/10/2022

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy